Article Details
Retrieved on: 2021-09-01 17:49:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The warnings stem from the U.S. Food and Drug Administration's review of Pfizer's arthritis drug Xeljanz after initial results from a February trial showed an ...
Article found on: kfgo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here